Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Jesse Schold to Treatment Outcome

This is a "connection" page, showing publications Jesse Schold has written about Treatment Outcome.

 
Connection Strength
  
 
 
1.451
  
  1. Heaphy EL, Poggio ED, Flechner SM, Goldfarb DA, Askar M, Fatica R, Srinivas TR, Schold JD. Risk factors for retransplant kidney recipients: relisting and outcomes from patients' primary transplant. Am J Transplant. 2014 Jun; 14(6):1356-67.
    View in: PubMed
    Score: 0.177
  2. Mohan S, King KL, Husain SA, Schold JD. COVID-19-Associated Mortality among Kidney Transplant Recipients and Candidates in the United States. Clin J Am Soc Nephrol. 2021 11; 16(11):1695-1703.
    View in: PubMed
    Score: 0.074
  3. Tsuang WM, Arrigain S, Lopez R, Snair M, Budev M, Schold JD. Patient Travel Distance and Post Lung Transplant Survival in the United States: A Cohort Study. Transplantation. 2020 11; 104(11):2365-2372.
    View in: PubMed
    Score: 0.070
  4. Schold JD, Miller CM, Henry ML, Buccini LD, Flechner SM, Goldfarb DA, Poggio ED, Andreoni KA. Evaluation of Flagging Criteria of United States Kidney Transplant Center Performance: How to Best Define Outliers? Transplantation. 2017 06; 101(6):1373-1380.
    View in: PubMed
    Score: 0.055
  5. Schold JD, Buccini LD, Phelan MP, Jay CL, Goldfarb DA, Poggio ED, Sedor JR. Building an Ideal Quality Metric for ESRD Health Care Delivery. Clin J Am Soc Nephrol. 2017 08 07; 12(8):1351-1356.
    View in: PubMed
    Score: 0.055
  6. Schold J, Poggio E, Goldfarb D, Kayler L, Flechner S. Clinical outcomes associated with induction regimens among retransplant kidney recipients in the United States. Transplantation. 2015 Jun; 99(6):1165-71.
    View in: PubMed
    Score: 0.048
  7. Schold JD, Buccini LD, Goldfarb DA, Flechner SM, Poggio ED, Sehgal AR. Association between kidney transplant center performance and the survival benefit of transplantation versus dialysis. Clin J Am Soc Nephrol. 2014 Oct 07; 9(10):1773-80.
    View in: PubMed
    Score: 0.046
  8. Schold JD, Heaphy EL, Buccini LD, Poggio ED, Srinivas TR, Goldfarb DA, Flechner SM, Rodrigue JR, Thornton JD, Sehgal AR. Prominent impact of community risk factors on kidney transplant candidate processes and outcomes. Am J Transplant. 2013 Sep; 13(9):2374-83.
    View in: PubMed
    Score: 0.042
  9. Heaphy ELG, Goldfarb DA, Poggio ED, Buccini LD, Flechner SM, Schold JD. The impact of deceased donor kidney risk significantly varies by recipient characteristics. Am J Transplant. 2013 Apr; 13(4):1001-1011.
    View in: PubMed
    Score: 0.041
  10. Kayler LK, Sokolich J, Magliocca J, Schold JD. Import kidney transplants from nonmandatory share deceased donors: characteristics, distribution and outcomes. Am J Transplant. 2011 Jan; 11(1):77-85.
    View in: PubMed
    Score: 0.035
  11. Srinivas TR, Flechner SM, Poggio ED, Askar M, Goldfarb DA, Navaneethan SD, Schold JD. Glomerular filtration rate slopes have significantly improved among renal transplants in the United States. Transplantation. 2010 Dec 27; 90(12):1499-505.
    View in: PubMed
    Score: 0.035
  12. Schold JD, Sehgal AR, Srinivas TR, Poggio ED, Navaneethan SD, Kaplan B. Marked variation of the association of ESRD duration before and after wait listing on kidney transplant outcomes. Am J Transplant. 2010 Sep; 10(9):2008-16.
    View in: PubMed
    Score: 0.034
  13. Schold JD, Kaplan B. The elephant in the room: failings of current clinical endpoints in kidney transplantation. Am J Transplant. 2010 May; 10(5):1163-6.
    View in: PubMed
    Score: 0.034
  14. Kayler LK, Magliocca J, Kim RD, Howard R, Schold JD. Single kidney transplantation from young pediatric donors in the United States. Am J Transplant. 2009 Dec; 9(12):2745-51.
    View in: PubMed
    Score: 0.033
  15. Schold JD, Santos A, Rehman S, Magliocca J, Meier-Kriesche HU. The success of continued steroid avoidance after kidney transplantation in the US. Am J Transplant. 2009 Dec; 9(12):2768-76.
    View in: PubMed
    Score: 0.033
  16. Schold JD, Kaplan B. AZA/tacrolimus is associated with similar outcomes as MMF/tacrolimus among renal transplant recipients. Am J Transplant. 2009 Sep; 9(9):2067-74.
    View in: PubMed
    Score: 0.032
  17. Kaplan B, Schold J. Transplantation: neural networks for predicting graft survival. Nat Rev Nephrol. 2009 Apr; 5(4):190-2.
    View in: PubMed
    Score: 0.031
  18. Schold JD, Rehman S, Kayle LK, Kayler LK, Magliocca J, Srinivas TR, Meier-Kriesche HU. Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States. Transpl Int. 2009 Jun; 22(6):626-34.
    View in: PubMed
    Score: 0.031
  19. Kayler LK, Garzon P, Magliocca J, Fujita S, Kim RD, Hemming AW, Howard R, Schold JD. Outcomes and utilization of kidneys from deceased donors with acute kidney injury. Am J Transplant. 2009 Feb; 9(2):367-73.
    View in: PubMed
    Score: 0.031
  20. Kayler LK, Magliocca J, Fujita S, Kim RD, Zendejas I, Hemming AW, Howard R, Schold JD. Recovery factors affecting utilization of small pediatric donor kidneys. Am J Transplant. 2009 Jan; 9(1):210-6.
    View in: PubMed
    Score: 0.030
  21. Schold JD, Srinivas TR, Howard RJ, Jamieson IR, Meier-Kriesche HU. The association of candidate mortality rates with kidney transplant outcomes and center performance evaluations. Transplantation. 2008 Jan 15; 85(1):1-6.
    View in: PubMed
    Score: 0.029
  22. Schold JD, Srinivas TR, Guerra G, Reed AI, Johnson RJ, Weiner ID, Oberbauer R, Harman JS, Hemming AW, Meier-Kriesche HU. A "weight-listing" paradox for candidates of renal transplantation? Am J Transplant. 2007 Mar; 7(3):550-9.
    View in: PubMed
    Score: 0.027
  23. Meier-Kriesche HU, Schold JD. The impact of pretransplant dialysis on outcomes in renal transplantation. Semin Dial. 2005 Nov-Dec; 18(6):499-504.
    View in: PubMed
    Score: 0.025
  24. Schold JD, Kaplan B, Howard RJ, Reed AI, Foley DP, Meier-Kriesche HU. Are we frozen in time? Analysis of the utilization and efficacy of pulsatile perfusion in renal transplantation. Am J Transplant. 2005 Jul; 5(7):1681-8.
    View in: PubMed
    Score: 0.024
  25. Augustine JJ, Arrigain S, Mandelbrot DA, Schold JD, Poggio ED. Factors Associated With Residual Kidney Function and Proteinuria After Living Kidney Donation in the United States. Transplantation. 2021 02 01; 105(2):372-381.
    View in: PubMed
    Score: 0.018
  26. Man S, Tang AS, Schold JD, Kolikonda MK, Uchino K. The Patterns and Outcomes of Inter-Hospital Transfer Among Medicare Patients with Ischemic Stroke. J Stroke Cerebrovasc Dis. 2020 Dec; 29(12):105331.
    View in: PubMed
    Score: 0.017
  27. Khanna A, Fedrigon D, Monga M, Gao T, Schold J, Abouassaly R. Postoperative Emergency Department Visits After Urinary Stone Surgery: Variation Based on Surgical Modality. J Endourol. 2020 01; 34(1):93-98.
    View in: PubMed
    Score: 0.016
  28. Man S, Schold JD, Uchino K. Case Fatality Decline from 2009 to 2013 among Medicare Beneficiaries with Ischemic Stroke. J Stroke Cerebrovasc Dis. 2020 Feb; 29(2):104559.
    View in: PubMed
    Score: 0.016
  29. Lehr CJ, Lopez R, Arrigain S, Schold J, Koval C, Valapour M. The impact of change in definition of increased-risk donors on survival after lung transplant. J Thorac Cardiovasc Surg. 2020 Aug; 160(2):572-581.
    View in: PubMed
    Score: 0.016
  30. Rodrigue JR, Fleishman A, Sokas CM, Schold JD, Morrissey P, Whiting J, Vella J, Kayler LK, Katz D, Jones J, Kaplan B, Pavlakis M, Mandelbrot DA. Rates of Living Kidney Donor Follow-up: Findings From the KDOC Study. Transplantation. 2019 07; 103(7):e209-e210.
    View in: PubMed
    Score: 0.016
  31. Sasaki K, Firl DJ, McVey JC, Schold JD, Iuppa G, Diago Uso T, Fujiki M, Aucejo FN, Quintini C, Eghetsad B, Miller CM, Hashimoto K. Elevated Risk of Split-Liver grafts in adult liver Transplantation: Statistical Artifact or Nature of the Beast? Liver Transpl. 2019 05; 25(5):741-751.
    View in: PubMed
    Score: 0.016
  32. Rincon-Choles H, Jolly SE, Arrigain S, Konig V, Schold JD, Nakhoul G, Navaneethan SD, Nally JV, Rothberg MB. Impact of Uric Acid Levels on Kidney Disease Progression. Am J Nephrol. 2017; 46(4):315-322.
    View in: PubMed
    Score: 0.014
  33. Navaneethan SD, Jolly SE, Schold JD, Arrigain S, Nakhoul G, Konig V, Hyland J, Burrucker YK, Dann PD, Tucky BH, Sharp J, Nally JV. Pragmatic Randomized, Controlled Trial of Patient Navigators and Enhanced Personal Health Records in CKD. Clin J Am Soc Nephrol. 2017 Sep 07; 12(9):1418-1427.
    View in: PubMed
    Score: 0.014
  34. O'Connell PJ, Kuypers DR, Mannon RB, Abecassis M, Chadban SJ, Gill JS, Murphy B, Nickerson PW, Schold JD, Stock PG, Seron D, Alloway RR, Bromberg JS, Budde K, Jordan SC, Legendre C, Lefaucheur C, Sarwall M, Segev DL, Stegall MD, Tullius SG, Wong G, Woodle ES, Ascher N, Morris RE. Clinical Trials for Immunosuppression in Transplantation: The Case for Reform and Change in Direction. Transplantation. 2017 07; 101(7):1527-1534.
    View in: PubMed
    Score: 0.014
  35. Koyawala N, Silber JH, Rosenbaum PR, Wang W, Hill AS, Reiter JG, Niknam BA, Even-Shoshan O, Bloom RD, Sawinski D, Nazarian S, Trofe-Clark J, Lim MA, Schold JD, Reese PP. Comparing Outcomes between Antibody Induction Therapies in Kidney Transplantation. J Am Soc Nephrol. 2017 Jul; 28(7):2188-2200.
    View in: PubMed
    Score: 0.014
  36. Nakhoul GN, Schold JD, Arrigain S, Harb SC, Jolly S, Wilkoff BL, Nally JV, Navaneethan SD. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis. Clin J Am Soc Nephrol. 2015 Jul 07; 10(7):1119-27.
    View in: PubMed
    Score: 0.012
  37. Saeed F, Adil MM, Malik AA, Schold JD, Holley JL. Outcomes of In-Hospital Cardiopulmonary Resuscitation in Maintenance Dialysis Patients. J Am Soc Nephrol. 2015 Dec; 26(12):3093-101.
    View in: PubMed
    Score: 0.012
  38. Rodrigue JR, Paek MJ, Egbuna O, Waterman AD, Schold JD, Pavlakis M, Mandelbrot DA. Making house calls increases living donor inquiries and evaluations for blacks on the kidney transplant waiting list. Transplantation. 2014 Nov 15; 98(9):979-86.
    View in: PubMed
    Score: 0.012
  39. Opelami O, Sakhuja A, Liu X, Tang WH, Schold JD, Navaneethan SD. Outcomes of infected cardiovascular implantable devices in dialysis patients. Am J Nephrol. 2014; 40(3):280-7.
    View in: PubMed
    Score: 0.011
  40. Navaneethan SD, Sakhuja A, Arrigain S, Sharp J, Schold JD, Nally JV. Practice patterns of phosphate binder use and their associations with mortality in chronic kidney disease. Clin Nephrol. 2014 Jul; 82(1):16-25.
    View in: PubMed
    Score: 0.011
  41. Crews DC, Scialla JJ, Boulware LE, Navaneethan SD, Nally JV, Liu X, Arrigain S, Schold JD, Ephraim PL, Jolly SE, Sozio SM, Michels WM, Miskulin DC, Tangri N, Shafi T, Wu AW, Bandeen-Roche K. Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD. Am J Kidney Dis. 2014 May; 63(5):806-15.
    View in: PubMed
    Score: 0.011
  42. Elfadawy N, Flechner SM, Schold JD, Srinivas TR, Poggio E, Fatica R, Avery R, Mossad SB. Transient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation. Clin J Am Soc Nephrol. 2014 Mar; 9(3):553-61.
    View in: PubMed
    Score: 0.011
  43. Elfadawy N, Flechner SM, Liu X, Schold J, Srinivas TR, Poggio E, Fatica R, Avery R, Mossad SB. CMV Viremia is associated with a decreased incidence of BKV reactivation after kidney and kidney-pancreas transplantation. Transplantation. 2013 Dec 27; 96(12):1097-103.
    View in: PubMed
    Score: 0.011
  44. Sakhuja A, Schold JD, Kumar G, Katzan I, Navaneethan SD. Nontraumatic subarachnoid hemorrhage in maintenance dialysis hospitalizations: trends and outcomes. Stroke. 2014 Jan; 45(1):71-6.
    View in: PubMed
    Score: 0.011
  45. Kayler LK, Wen X, Zachariah M, Casey M, Schold J, Magliocca J. Outcomes and survival analysis of old-to-old simultaneous pancreas and kidney transplantation. Transpl Int. 2013 Oct; 26(10):963-72.
    View in: PubMed
    Score: 0.010
  46. Sakhuja A, Schold JD, Kumar G, Dall A, Sood P, Navaneethan SD. Outcomes of patients receiving maintenance dialysis admitted over weekends. Am J Kidney Dis. 2013 Oct; 62(4):763-70.
    View in: PubMed
    Score: 0.010
  47. Grams ME, Massie AB, Schold JD, Chen BP, Segev DL. Trends in the inactive kidney transplant waitlist and implications for candidate survival. Am J Transplant. 2013 Apr; 13(4):1012-1018.
    View in: PubMed
    Score: 0.010
  48. Askar M, Schold JD, Eghtesad B, Flechner SM, Kaplan B, Klingman L, Zein NN, Fung J, Srinivas TR. Combined liver-kidney transplants: allosensitization and recipient outcomes. Transplantation. 2011 Jun 15; 91(11):1286-92.
    View in: PubMed
    Score: 0.009
  49. Demirjian S, Teo BW, Guzman JA, Heyka RJ, Paganini EP, Fissell WH, Schold JD, Schreiber MJ. Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury. Nephrol Dial Transplant. 2011 Nov; 26(11):3508-14.
    View in: PubMed
    Score: 0.009
  50. Kayler LK, Schold JD, Magliocca JF. Response: DonorNet and the potential effects on organ utilization. Am J Transplant. 2010 Oct; 10(10):2376; author reply 2377.
    View in: PubMed
    Score: 0.009
  51. Scornik JC, Guerra G, Schold JD, Srinivas TR, Dragun D, Meier-Kriesche HU. Value of posttransplant antibody tests in the evaluation of patients with renal graft dysfunction. Am J Transplant. 2007 Jul; 7(7):1808-14.
    View in: PubMed
    Score: 0.007
  52. Srinivas TR, Schold JD, Guerra G, Eagan A, Bucci CM, Meier-Kriesche HU. Mycophenolate mofetil/sirolimus compared to other common immunosuppressive regimens in kidney transplantation. Am J Transplant. 2007 Mar; 7(3):586-94.
    View in: PubMed
    Score: 0.007
  53. Reddy V, Winer AG, Eksioglu E, Meier-Kriesche HU, Schold JD, Wingard JR. Interleukin 12 is associated with reduced relapse without increased incidence of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005 Dec; 11(12):1014-21.
    View in: PubMed
    Score: 0.006
  54. Srinivas TR, Kaplan B, Schold JD, Meier-Kriesche HU. The impact of mycophenolate mofetil on long-term outcomes in kidney transplantation. Transplantation. 2005 Oct 15; 80(2 Suppl):S211-20.
    View in: PubMed
    Score: 0.006
  55. Meier-Kriesche HU, Schold JD, Srinivas TR, Howard RJ, Fujita S, Kaplan B. Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus. Am J Transplant. 2005 Sep; 5(9):2273-80.
    View in: PubMed
    Score: 0.006
  56. Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant. 2004 Aug; 4(8):1289-95.
    View in: PubMed
    Score: 0.006
  57. Kaplan B, Schold JD, Meier-Kriesche HU. Long-term graft survival with neoral and tacrolimus: a paired kidney analysis. J Am Soc Nephrol. 2003 Nov; 14(11):2980-4.
    View in: PubMed
    Score: 0.005
  58. Kaplan B, Schold J, Meier-Kriesche HU. Overview of large database analysis in renal transplantation. Am J Transplant. 2003 Sep; 3(9):1052-6.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)